Susquehanna International Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.45M | Sell |
37,400
-47,400
| -56% | -$8.79M | ﹤0.01% | 3818 |
|
|
2025
Q4 | $16.9M | Sell |
84,800
-22,000
| -21% | -$3.99M | ﹤0.01% | 2386 |
|
|
2025
Q3 | $16.7M | Buy |
106,800
+600
| +0.6% | +$95.3K | ﹤0.01% | 2396 |
|
|
2025
Q2 | $16.1M | Buy |
106,200
+71,400
| +205% | +$9.52M | ﹤0.01% | 2255 |
|
|
2025
Q1 | $5.24M | Buy |
34,800
+1,000
| +3% | +$168K | ﹤0.01% | 3565 |
|
|
2024
Q4 | $6.24M | Sell |
33,800
-2,000
| -6% | -$385K | ﹤0.01% | 3273 |
|
|
2024
Q3 | $7.05M | Sell |
35,800
-1,600
| -4% | -$333K | ﹤0.01% | 3074 |
|
|
2024
Q2 | $7.73M | Buy |
37,400
+2,800
| +8% | +$634K | ﹤0.01% | 2813 |
|
|
2024
Q1 | $9.37M | Buy |
34,600
+700
| +2% | +$167K | ﹤0.01% | 2692 |
|
|
2023
Q4 | $8.01M | Buy |
33,900
+1,900
| +6% | +$374K | ﹤0.01% | 2951 |
|
|
2023
Q3 | $6.27M | Sell |
32,000
-16,800
| -34% | -$3.45M | ﹤0.01% | 3184 |
|
|
2023
Q2 | $10.3M | Buy |
48,800
+8,600
| +21% | +$1.71M | ﹤0.01% | 2477 |
|
|
2023
Q1 | $8.11M | Sell |
40,200
-14,900
| -27% | -$3.38M | ﹤0.01% | 2753 |
|
|
2022
Q4 | $12M | Buy |
55,100
+11,000
| +25% | +$2.4M | ﹤0.01% | 2038 |
|
|
2022
Q3 | $8.68M | Buy |
44,100
+3,300
| +8% | +$712K | ﹤0.01% | 2368 |
|
|
2022
Q2 | $8.73M | Sell |
40,800
-11,000
| -21% | -$2.69M | ﹤0.01% | 2392 |
|
|
2022
Q1 | $14.7M | Sell |
51,800
-10,300
| -17% | -$3.18M | ﹤0.01% | 2054 |
|
|
2021
Q4 | $23.4M | Sell |
62,100
-28,200
| -31% | -$11M | ﹤0.01% | 1705 |
|
|
2021
Q3 | $37.3M | Buy |
90,300
+41,800
| +86% | +$17.4M | 0.01% | 1383 |
|
|
2021
Q2 | $17.9M | Buy |
48,500
+19,300
| +66% | +$6.44M | ﹤0.01% | 2172 |
|
|
2021
Q1 | $8.46M | Sell |
29,200
-45,100
| -61% | -$12.5M | ﹤0.01% | 3048 |
|
|
2020
Q4 | $18.6M | Sell |
74,300
-20,200
| -21% | -$4.81M | ﹤0.01% | 1824 |
|
|
2020
Q3 | $21.4M | Sell |
94,500
-129,600
| -58% | -$26.9M | ﹤0.01% | 1427 |
|
|
2020
Q2 | $39.1M | Buy |
224,100
+82,300
| +58% | +$13.1M | 0.01% | 961 |
|
|
2020
Q1 | $17.9M | Buy |
141,800
+87,800
| +163% | +$13.2M | 0.01% | 1255 |
|
|
2019
Q4 | $8.25M | Buy |
54,000
+30,000
| +125% | +$4.15M | ﹤0.01% | 2308 |
|
|
2019
Q3 | $3.18M | Sell |
24,000
-1,900
| -7% | -$255K | ﹤0.01% | 3399 |
|
|
2019
Q2 | $3.67M | Sell |
25,900
-38,700
| -60% | -$5.25M | ﹤0.01% | 3145 |
|
|
2019
Q1 | $9.38M | Buy |
64,600
+21,400
| +50% | +$2.81M | ﹤0.01% | 1798 |
|
|
2018
Q4 | $4.89M | Buy |
43,200
+36,700
| +565% | +$4.6M | ﹤0.01% | 2310 |
|
|
2018
Q3 | $875K | Sell |
6,500
-1,700
| -21% | -$210K | ﹤0.01% | 5486 |
|
|
2018
Q2 | $921K | Sell |
8,200
-11,300
| -58% | -$1.22M | ﹤0.01% | 5528 |
|
|
2018
Q1 | $2.08M | Sell |
19,500
-10,400
| -35% | -$1.12M | ﹤0.01% | 3844 |
|
|
2017
Q4 | $3.27M | Buy |
29,900
+20,600
| +222% | +$2.24M | ﹤0.01% | 3096 |
|
|
2017
Q3 | $1M | Sell |
9,300
-8,600
| -48% | -$884K | ﹤0.01% | 5258 |
|
|
2017
Q2 | $1.81M | Buy |
17,900
+4,900
| +38% | +$451K | ﹤0.01% | 4087 |
|
|
2017
Q1 | $1.17M | Buy |
13,000
+600
| +5% | +$51K | ﹤0.01% | 4792 |
|
|
2016
Q4 | $945K | Sell |
12,400
-69,500
| -85% | -$5.28M | ﹤0.01% | 5654 |
|
|
2016
Q3 | $6.83M | Buy |
81,900
+41,300
| +102% | +$3.46M | ﹤0.01% | 1888 |
|
|
2016
Q2 | $3.35M | Buy |
40,600
+3,000
| +8% | +$247K | ﹤0.01% | 2758 |
|
|
2016
Q1 | $2.85M | Buy |
37,600
+27,400
| +269% | +$2.03M | ﹤0.01% | 3133 |
|
|
2015
Q4 | $820K | Sell |
10,200
-1,000
| -9% | -$72.1K | ﹤0.01% | 5814 |
|
|
2015
Q3 | $711K | Sell |
11,200
-27,000
| -71% | -$1.94M | ﹤0.01% | 6432 |
|
|
2015
Q2 | $2.69M | Buy |
+38,200
| New | +$2.83M | ﹤0.01% | 4071 |
|
|
2014
Q4 | – | Sell |
-5,800
| Closed | -$346K | – | 9656 |
|
|
2014
Q3 | $346K | Sell |
5,800
-29,200
| -83% | -$1.67M | ﹤0.01% | 7802 |
|
|
2014
Q2 | $1.87M | Buy |
35,000
+30,600
| +695% | +$1.68M | ﹤0.01% | 4783 |
|
|
2014
Q1 | $265K | Sell |
4,400
-8,700
| -66% | -$507K | ﹤0.01% | 7787 |
|
|
2013
Q4 | $695K | Sell |
13,100
-43,300
| -77% | -$2.17M | ﹤0.01% | 6156 |
|
|
2013
Q3 | $2.61M | Buy |
56,400
+17,600
| +45% | +$808K | ﹤0.01% | 3691 |
|
|
2013
Q2 | $1.59M | Buy |
+38,800
| New | +$1.66M | ﹤0.01% | 4265 |
|
Other funds holding CRL
VCM
VPM
Susquehanna International Group's CRL Position: Q1 2026 in Review
Susquehanna International Group reduced its Charles River Laboratories (CRL) stake by 20% in Q1 2026, selling an estimated $874K and leaving 18,995 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #5093.
Susquehanna International Group first reported a position in CRL in Q2 2013 and has held it in 39 quarters since. The position peaked at $13.3M in Q4 2021. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Susquehanna International Group held 18,995 shares of Charles River Laboratories worth $3.28M as of Q1 2026.
- Susquehanna International Group sold 4,712 Charles River Laboratories shares in Q1 2026, an estimated $874K.
- Charles River Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5093 holding.
- Susquehanna International Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 39 quarters since.
- Susquehanna International Group's Charles River Laboratories position peaked at $13.3M in Q4 2021.
- 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.